Serious Issues With Slow Heartbeat Flagged for Afib Patients on Antiarrhythmics
Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic drugs (AADs) had several-fold higher risks of cardiac events believed to be related to a decline in heart rate. Compared with other Afib patients, these AAD users showed […]
Start Rhythm Control Early for Afib With Heart Failure
Tackling rhythm control early, with ablation or antiarrhythmic medication in the first year after atrial fibrillation (Afib) diagnosis, helped outcomes in people with heart failure (HF), a prespecified subanalysis of the EAST-AFNET 4 trial showed. The early strategy cut the composite of cardiovascular death, stroke, or hospitalization for worsening HF or for acute coronary syndrome […]